Skip to main content

Table 3 Characterization of AHAD11, B157, LERU301, and SH3 at hD1 receptors used for 3D-QSAR analysis.

From: Dibenzazecine compounds with a novel dopamine/5HT2A receptor profile and 3D-QSAR analysis

 

Compound

 

AHAD11

B157

LERU301

SH3

pK i (hD1)

5.82 ± 0.07

6.98 ± 0.05

7.26 ± 0.03

6.17 ± 0.04

  1. Displayed are pK i values ± SEM, n ≥ 3.